M. Girard et al., REVERSED-PHASE LC ASSAY-METHOD FOR DEOXYCHOLATE IN INFLUENZA VACCINE, Journal of pharmaceutical and biomedical analysis, 12(6), 1994, pp. 833-837
Sodium deoxycholate is used for the disruption of particles in the man
ufacturing of some influenza vaccines. Residual deoxycholate in inacti
vated vaccines is currently determined using a labour-intensive colori
metric method which lacks complete specificity. An alternative assay m
ethod for residual deoxycholate in vaccine preparations was developed
using reversed-phase LC. Cholic acid was used as internal standard and
the ratio of internal standard to test solute was used for all calcul
ations. Prior to LC analysis, deoxycholic acid was concentrated by sol
id-phase extraction, a procedure that also removed proteinaceous mater
ial in vaccine samples. The clean-up/concentration procedure recovery
was examined using untreated samples and was found to be quantitative.
The linearity range of the LC method was between 3 and 200 mu g ml(-1
), with a limit of detection of approximately 0.4 mu g on column. and
a lower limit of quantitation of 1.6 mu g on column. Replicate assays
during intra- and inter-day experiments gave acceptable levels of vari
ability. The DCA content of samples from three lots of influenza vacci
ne varied between 10 and 16 mu g ml(-1) These values were appreciably
lower than those measured spectrophotometrically, indicating the highe
r specificity of the LC method.